Sartorius | SRT3 - EPS Earnings Per Share

Stock Price
214.25
Daily Change
-0.65 -0.30%
Monthly
0.54%
Yearly
-5.74%
Q2 Forecast
232.54

Sartorius reported EUR1.2 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 1.20 1.3 1.22 Apr/23
FY2025Q4 Dec/2025 1.27 1.33 1.04 Feb/03
FY2025Q3 Sep/2025 0.63 1.08 0.21 Oct/16
FY2025Q2 Jun/2025 0.47 1.28 0.34 Jul/22
FY2025Q1 Mar/2025 1.22 0.98 1.01 Apr/16




Eps Change Date
Akebia Therapeutics USD -0.04 0.04 Dec/2025
Alaunos Therapeutics USD -0.53 0.08 Sep/2025
Avita Medical AUD -0.38 0 Dec/2025
Dianthus Therapeutics USD -1.43 0.46 Dec/2025
Ionis Pharmaceuticals USD -1.41 0.61 Dec/2025
IQVIA Holdings USD 3.42 0.42 Dec/2025
Moderna USD -2.11 1.6 Dec/2025
Organon & Co USD 0.63 0.38 Dec/2025
Revvity USD 1.7 0.52 Dec/2025
Sartorius EUR 1.2 0.06 Mar/2026
Tectonic Therapeutic USD -1.03 0.01 Dec/2025
Viatris USD 0.57 0.1 Dec/2025
Xeris Pharmaceuticals USD 0.05 0.05 Dec/2025